狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            產(chǎn)品推薦:氣相|液相|光譜|質(zhì)譜|電化學(xué)|元素分析|水分測(cè)定儀|樣品前處理|試驗(yàn)機(jī)|培養(yǎng)箱


            化工儀器網(wǎng)>技術(shù)中心>其他文章>正文

            歡迎聯(lián)系我

            有什么可以幫您? 在線咨詢

            英國(guó)NIBSC標(biāo)準(zhǔn)品WHO標(biāo)準(zhǔn)品應(yīng)用

            來源:深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司   2017年02月07日 11:49  

            英國(guó)NIBSC標(biāo)準(zhǔn)品WHO標(biāo)準(zhǔn)品是深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司的熱銷產(chǎn)品,主要應(yīng)用在哪些領(lǐng)域呢?

            英國(guó)國(guó)家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對(duì)投入英國(guó)市場(chǎng)的生物藥品的獨(dú)立測(cè)試,尤其是用于英國(guó)兒童免疫計(jì)劃的疫苗;它同時(shí)也是歐盟控制藥品進(jìn)入歐盟市場(chǎng)的藥品控制實(shí)驗(yàn)室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題,NIBSC 也可對(duì)已投入歐盟市場(chǎng)的產(chǎn)品進(jìn)行檢驗(yàn)。

            NIBSC 戰(zhàn)略目標(biāo):對(duì)有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議;提供生物藥品方面的國(guó)家科技力量,維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識(shí)和設(shè)施;

            作為化驗(yàn)方法(如量化生物學(xué)活性以及確定生物產(chǎn)品特征和進(jìn)行安全評(píng)估)方面的機(jī)構(gòu)運(yùn)營(yíng)并得到認(rèn)同;

            在歐洲生物產(chǎn)品的控制和標(biāo)準(zhǔn)化方面,繼續(xù)發(fā)揮科學(xué)基礎(chǔ)開發(fā)的中心作用;

            在生物藥品法規(guī)的科學(xué)方面幫助社會(huì)達(dá)成共識(shí),并籍于此,與世界衛(wèi)生組織緊密合作;

            在控制和標(biāo)準(zhǔn)化的關(guān)鍵領(lǐng)域?qū)崿F(xiàn)和維護(hù)質(zhì)量鑒定。

            生物藥品控制

            藥品中使用的生物物質(zhì)包括病毒和細(xì)菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細(xì)胞分裂素和生長(zhǎng)素等治療藥物。

            這些生物物質(zhì)對(duì)藥物學(xué)和公眾健康做出了巨大貢獻(xiàn)并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預(yù)防、診斷和治療。

             

            深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司所售英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:

            (篇幅有限,更多產(chǎn)品,歡迎進(jìn)入我司展臺(tái)查詢)

            07/288BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent)
            01/535Meningococcal serogroup W polysaccharide
            07/352BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent)
            07/281BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent)
            10/164Reteplase Reference Material
            95/571Interleukin-32 (Human, rDNA derived)
            13/219Influenza Antigen B/Massachusetts/02/2097 (Egg derived)
            10/149Reteplase Reference Material
            07/344BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent)
            01/484Meningococcal serogroup W polysaccharide
            13/154Influenza Antigen B/Massachusetts/02/2032 (Egg derived)
            13/151Influenza Antigen B/Massachusetts/02/2029 (Egg derived)
            10/143Reteplase Reference Material
            01/476Meningococcal serogroup W polysaccharide
            12/B623-057QCRFLUAH1N1QC1-Influenza AH1N1 QC55
            12/B623-053QCRFLUAH1N1QC1-Influenza AH1N1 QC51
            12/B623-051QCRFLUAH1N1QC1-Influenza AH1N1 QC49
            13/275Polio Anti Sabin type 58 (inactivated) Serum
            12/B623-003QCRFLUAH1N1QC1-Influenza AH1N1 QC1
            07/315BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)
            13/285Polio Anti Sabin type 68 (inactivated) Serum
            03/104-019HTLV-4 (antibody) Monitor Sample
            13/153Influenza Antigen B/Massachusetts/02/2031 (Egg derived)
            12/B623-097QCRFLUAH1N1QC1-Influenza AH1N1 QC95
            10/144Reteplase Reference Material
            95/657Interleukin-118 (Human, rDNA derived)
            13/219Polio Anti Sabin type 2 (inactivated) Serum
            03/104-085HTLV-70 (antibody) Monitor Sample
            01/472Meningococcal serogroup W polysaccharide
            13/146Influenza Antigen B/Massachusetts/02/2024 (Egg derived)
            07/329BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent)
            13/165Influenza Antigen B/Massachusetts/02/2043 (Egg derived)
            13/281Polio Anti Sabin type 64 (inactivated) Serum
            07/306BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent)
            03/104-110HTLV-95 (antibody) Monitor Sample
            07/358BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)
            01/452Meningococcal serogroup W polysaccharide
            13/277Polio Anti Sabin type 60 (inactivated) Serum
            07/287BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)
            13/287Polio Anti Sabin type 70 (inactivated) Serum
            13/307Polio Anti Sabin type 90 (inactivated) Serum
            10/186Reteplase Reference Material
            10/133Reteplase Reference Material
            03/104-094HTLV-79 (antibody) Monitor Sample
            12/B623-031QCRFLUAH1N1QC1-Influenza AH1N1 QC29
            07/377BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent)
            13/269Polio Anti Sabin type 52 (inactivated) Serum
            10/179Reteplase Reference Material
            10/210Reteplase Reference Material
            13/266Polio Anti Sabin type 49 (inactivated) Serum
            07/295BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent)
            07/371BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent)
            12/B623-078QCRFLUAH1N1QC1-Influenza AH1N1 QC76
            01/462Meningococcal serogroup W polysaccharide
            95/591Interleukin-52 (Human, rDNA derived)
            01/464Meningococcal serogroup W polysaccharide
            10/159Reteplase Reference Material
            03/104-046HTLV-31 (antibody) Monitor Sample
            13/213C-Peptide, Human. 68st International Standard.
            13/222Influenza Antigen B/Massachusetts/02/2100 (Egg derived)
            07/373BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)
            12/B623-110QCRFLUAH1N1QC1-Influenza AH1N1 QC108
            13/196C-Peptide, Human. 51st International Standard.
            12/B623-043QCRFLUAH1N1QC1-Influenza AH1N1 QC41
            01/494Meningococcal serogroup W polysaccharide
            13/192Influenza Antigen B/Massachusetts/02/2070 (Egg derived)
            07/325BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent)
            07/348BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent)
            13/223Influenza Antigen B/Massachusetts/02/2101 (Egg derived)
            12/B623-086QCRFLUAH1N1QC1-Influenza AH1N1 QC84
            13/191Influenza Antigen B/Massachusetts/02/2069 (Egg derived)
            01/488Meningococcal serogroup W polysaccharide
            07/343BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent)
            12/B623-019QCRFLUAH1N1QC1-Influenza AH1N1 QC17
            10/125Reteplase Reference Material
            10/155Reteplase Reference Material
            13/185Influenza Antigen B/Massachusetts/02/2063 (Egg derived)
            13/243C-Peptide, Human. 98st International Standard.
            13/137Influenza Antigen B/Massachusetts/02/2015 (Egg derived)
            13/201C-Peptide, Human. 56st International Standard.
            07/311BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent)
            13/242C-Peptide, Human. 97st International Standard.
            13/175C-Peptide, Human. 30st International Standard.
            13/201Influenza Antigen B/Massachusetts/02/2079 (Egg derived)
            03/104-041HTLV-26 (antibody) Monitor Sample
            03/104-074HTLV-59 (antibody) Monitor Sample
            95/646Interleukin-107 (Human, rDNA derived)
            13/156C-Peptide, Human. 11st International Standard.
            01/465Meningococcal serogroup W polysaccharide
            03/104-050HTLV-35 (antibody) Monitor Sample
            10/121Reteplase Reference Material
            13/235Influenza Antigen B/Massachusetts/02/2113 (Egg derived)
            01/519Meningococcal serogroup W polysaccharide
            07/364BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)
            95/566Interleukin-27 (Human, rDNA derived)
            13/204C-Peptide, Human. 59st International Standard.
            13/205Influenza Antigen B/Massachusetts/02/2083 (Egg derived)
            13/241C-Peptide, Human. 96st International Standard.
            07/324BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)
            95/626Interleukin-87 (Human, rDNA derived)

            免責(zé)聲明

            • 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
            • 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
            • 如涉及作品內(nèi)容、版權(quán)等問題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。
            企業(yè)未開通此功能
            詳詢客服 : 0571-87858618